The anti-obesity effect of namodenoson, an A3 adenosine receptor agonist.
- DOI
- 10.1038/s41366-026-02017-2
- Published
- 2026 Apr
- Container
- International journal of obesity (2005)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41366-026-02017-2,
title = {The anti-obesity effect of namodenoson, an A3 adenosine receptor agonist.},
author = {Fishman P and Itzhak I and Safadi R and Amer J and Salhab A and Bareket-Samish A},
year = {2026},
journal = {International journal of obesity (2005)},
doi = {10.1038/s41366-026-02017-2},
url = {https://doi.org/10.1038/s41366-026-02017-2}
}RIS
TY - JOUR TI - The anti-obesity effect of namodenoson, an A3 adenosine receptor agonist. AU - Fishman P AU - Itzhak I AU - Safadi R AU - Amer J AU - Salhab A AU - Bareket-Samish A PY - 2026 JO - International journal of obesity (2005) DO - 10.1038/s41366-026-02017-2 UR - https://doi.org/10.1038/s41366-026-02017-2 ER -
APA
P, F., I, I., R, S., J, A., A, S., & A, B. (2026). The anti-obesity effect of namodenoson, an A3 adenosine receptor agonist.. International journal of obesity (2005). https://doi.org/10.1038/s41366-026-02017-2
Source records
- pubmed · retrieved 2026-09-25T23:29:45.185Z
- europe-pmc · retrieved 2026-09-25T23:29:45.197Z